Recapitulate human disease in advanced cellular and organoid systems to uncover disease mechanisms, identify therapeutic targets, and evaluate novel therapies.
Disease modeling using human cell and organoid platforms enables the study of disease processes in physiologically relevant systems that closely reflect human biology. By combining patient-derived cells, genome engineering, and organoid technologies, complex disease phenotypes can be investigated in vitro, providing valuable insights into disease progression and therapeutic response.
At Nocteva, we develop customized disease models tailored to specific research questions and therapeutic programs, supporting projects from early discovery through preclinical validation.
Disease Modeling
Why Use Human Disease Models?
Traditional cell lines and animal models often fail to fully capture the complexity of human disease. Human cell and organoid models provide a more relevant platform for studying disease mechanisms and evaluating potential therapies.
Conventional
Immortalized cell lines & animal models
Often fail to capture the genetics, complexity, and tissue architecture of human disease, or to reflect a specific patient.
Nocteva approach
Patient-derived iPSC cells & organoids
A patient's own tissue or blood is reprogrammed into induced pluripotent stem cells (iPSCs), then differentiated into disease-relevant cell types and 3D organoids — preserving the patient's genetic background.
Disease Modeling
Key Advantages
Human-relevant biology
Patient-specific and genetically defined models
Advanced 3D tissue architecture
Mechanistic insights into disease progression
Drug screening and efficacy testing
Biomarker discovery
Reduced reliance on animal models
Scalable and reproducible experimental systems
Disease Modeling
Model Systems
Patient-Derived iPSC Models
Generate disease-relevant cell types from patient-derived induced pluripotent stem cells while preserving the patient's genetic background.
Organoid Disease Models
Three-dimensional organoid systems that reproduce key structural and functional characteristics of human tissues and organs.
Available platforms
BrainRetinalCardiacSkeletal & muscleLung
Genome-Engineered Models
Introduce or correct disease-associated mutations using CRISPR-based approaches to create isogenic disease and control models.
Process
Disease Modeling Workflow
01
Project Design
Define disease indication, biological questions, and experimental endpoints.
02
Model Generation
Establish disease-relevant cellular or organoid models from patient-derived, engineered, or control cell lines.
03
Characterization
Validate molecular, cellular, structural, and functional phenotypes.
04
Functional Studies
Investigate disease mechanisms and identify disease-associated phenotypes.
05
Therapeutic Evaluation
Assess drug candidates, gene therapies, and other therapeutic interventions.
Disease Areas
Available Disease Models
Our disease modeling platforms can be customized across a broad range of disease indications. Available models include patient-derived, genome-engineered, and organoid-based systems for mechanistic studies, target validation, and therapeutic development.
Available as patient-derived iPSC and organoid models.
Neurodegenerative Disorders
Alzheimer's Disease
Parkinson's Disease
Amyotrophic Lateral Sclerosis (ALS)
Huntington's Disease
Available as neuronal cultures and organoid-based systems.
Retinal Disorders
Retinitis Pigmentosa (RP11)
Inherited Retinal Degeneration Models
Available as retinal organoid platforms for disease modeling and therapeutic evaluation.
Custom Disease Models
Don't see your disease area listed?
We offer customized disease modeling programs using patient-derived samples, existing iPSC lines, genome engineering, and organoid technologies tailored to your specific research needs.
Contact
Interested in our services?
We collaborate with researchers, clinicians, and patient communities to drive innovation where it’s needed most.
Your submission has been received!
Oops! Something went wrong while submitting the form.
